Roberto Mignone sold $6.3M of Teva Pharmaceutical Industries Limited (TEVA)

Executed Dec 20 2024, disclosed Dec 26 2024, 6 days later, against a two-business-day limit.

Value, as filed

$6.3M

286,000 sh × $22.01

Executed

Dec 20 2024

the trade date, as filed

Disclosed

Dec 26 2024

6 days after the trade · past the deadline

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Roberto Mignone Director profile →

Roberto Mignone (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Teva Pharmaceutical Industries Limited (TEVA). The largest single filing was $4.8M of TEVA (200,000 sh × $24.11, as filed), executed Nov 6 2025.

The name

TEVA

Teva Pharmaceutical Industries Limited TEVA · Healthcare · 56 filings in 24 months ticker →

Healthcare · Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Roberto Mignone in TEVA

TEVASALE Teva Pharmaceutical Industries Limited $2.3M
77,400 sh × $30.24
Exec Dec 16 2025
Filed Dec 18 2025 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $1.3M
50,000 sh × $26.03
Exec Nov 26 2025
Filed Dec 1 2025 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $4.8M
200,000 sh × $24.11
Exec Nov 6 2025
Filed Nov 10 2025 · 5:30 PM ET